Literature DB >> 299685

Mental confusion and epileptic seizures following cervical myelography with metrizamide. Report of a case.

O Sortland1, A Lundervold, R Nesbakken.   

Abstract

A case of alarming, but transient clinical and EEG disturbances following cervical myelography with metrizamide (Amipaque) is reported. Clinically, mental disturbances and epileptic seizures were prominent, while bilateral rhythmic slow waves and spikes occurred in the EEG recordings.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 299685

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN： 0365-5954


  9 in total

1.  Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.

Authors:  Y L Yu; G H du Boulay; E Paul
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

2.  Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelography.

Authors:  S Richert; K Sartor; B Holl
Journal:  Neuroradiology       Date:  1979-10-31       Impact factor: 2.804

3.  Is there an increased risk of early side effects of metrizamide in post-myelogram computed tomography?

Authors:  Y L Yu; G H du Boulay
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

4.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

5.  Cervical myelography with iohexol.

Authors:  P Nakstad; O Aaserud; A Helgetveit; R Nyberg-Hansen; T Ganes; T Bach-Gansmo
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

6.  Iopamidol vs metrizamide: a double blind study for cervical myelography.

Authors:  B P Drayer; M A Warner; A Sudilovsky; J Luther; R Wilkins; S Allen; M Bates
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

7.  The distribution of 125I-metrizamide and 125I-diatrizoate between blood, brain and cerebrospinal fluid in the rabbit.

Authors:  J D Fenstermacher; M W Bradbury; G du Boulay; B E Kendall; E W Radu
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

8.  Myelography with iohexol (Omnipaque); a clinical report with special reference to the adverse effects.

Authors:  I O Skalpe; P Nakstad
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

9.  Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.

Authors:  P Nakstad; A Helgetveit; O Aaserud; T Ganes; R Nyberg-Hansen
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.